Clinical value of ultrasound-guided polidocanol foam sclerotherapy for renal cysts

doi:10.3877/cma.j.issn.2095-5782.2022.03.011

Abstract

Abstract:

Objective

To explore the clinical value of ultrasound-guided polidocanol foam in sclerotherapy of renal cysts.

Methods

Analysis of our hospital from January 2019 to June 2020, 42 cases of renal cysts, ultrasound guided polidocanol foam sclerotherapy, all patients at 1, 3, 6, 12 months after operation regular follow-up ultrasound, according to the reduction rate of cyst to evaluate the curative effect.

Results

42 renal cysts of 42 patients were followed up 1, 3, 6 and 12 months after operation.The cure rates were 11.9%, 35.7%, 42.9% and 59.5% respectively; The total effective rates were 59.5%, 83.3%, 92.9% and 100.0% respectively. Cox multivariate regression analysis showed that the size of cyst volume was the main factor affecting the therapeutic effect of polidocanol.

Conclusions

Ultrasound guided polidocanol foam sclerotherapy for renal cyst is safe and effective, the longer the follow-up time is, the more effective the treatment is, and the smaller the cyst volume, the more accurate the curative effect is,which is worthy of clinical application.

Key words: Ultrasound-guided, Renal cyst, Polidocanol, Sclerotherapy

Jiaxun Wang, Yujing Chen, Zhanpeng Liang, Zhuoqiang Wu, Jiaming Wu, Yidi Lin. Clinical value of ultrasound-guided polidocanol foam sclerotherapy for renal cysts[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(03): 278-282.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2022.03.011

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2022/V10/I03/278

Figures/Tables 4

References 15

[1]	Nalagatla S, Manson R, McLennan R, et al. Laparoscopic decortication of simple renal cysts: a systematic review and meta-analysis to determine efficacy and safety of this procedure[J]. Urologia Internationalis, 2019, 103(2): 235-241.
[2]	王星渊, 曹德宏, 陈泽昱, 等. 彩超引导下经皮穿刺硬化与腹腔镜去顶减压术治疗单纯性肾囊肿的Meta分析[J]. 现代泌尿外科杂志, 2019, 24(10): 806-811, 820.
[3]	Seyam OA, Elshimy AS, Niazi GEM, et al. Ultrasound-guided percutaneous injection of foam sclerotherapy in management of lower limb varicose veins (pilot study)[J]. Egyptian Journal of Radiology and Nuclear Medicine, 2020, 51(1): 175.
[4]	Polimanti AC, Pereira LA, Carmine TM, et al. Influence of polidocanol ultrasound-guided foam sclerotherapy on quality of life in lower extremity chronic venous disease: initial results[J].J Vasc Bras, 18: e20190049.
[5]	方鸿, 肖露蓉, 宫雪. 超声引导下注射聚桂醇硬化治疗肝肾囊肿的临床效果[J]. 实用临床医药杂志, 2019, 23(12): 5-7.
[6]	Sui G, Fei D, Luo Q. Comparison of the therapeutic effects of polycinnamol and anhydrous alcohol in the treatment of hepatic cysts with puncture and sclerosis under the guidance of ultrasound[J]. AIP Conference Proceedings, 2019, 2058(1): 020037.
[7]	Xu S, Rao M, Pu Y, et al. The efficacy of laparoscopic lauromacrogol sclerotherapy in the treatment of simple hepatic cysts located in posterior segments: a refined surgical approach[J]. Annals of Palliative Medicine, 2020, 9(5): 3462-3471.
[8]	Eso Y, Furuta A, Takai A, et al. Ultrasound-guided microfoam sclerotherapy with polidocanol for symptomatic giant hepatic cyst: Initial experience[J]. Hepatology Research, 2018, 48(12): 1055-1063.
[9]	吴咏兵. 聚多卡醇泡沫硬化剂治疗下肢静脉曲张的临床效果分析[J]. 临床医药文献电子杂志, 2019, 6(52): 176, 178.
[10]	刘振斌, 王刚, 李梦虎, 等. 超声引导下聚多卡醇注射治疗复发下肢静脉曲张的临床研究[J]. 中国中西医结合外科杂志, 2019, 25(5): 767-770.
[11]	Mesa-álvarez L, Salgado-Boquete L, Flórez-Menéndez Má. An 18-month follow-up of digital myxoid cysts after therapy with percutaneous sclerotherapy with polidocanol[J]. Dermatologic Surgery, 2018, 44(1): 140-142.
[12]	彭娟, 钱婷婷, 朱梅, 等. 超声引导不同方法制作聚桂醇泡沫硬化治疗肾囊肿的临床疗效评价[J]. 西部医学, 2018, 30(2): 283-286.
[13]	冼建忠, 卢吴柱, 陈晓波, 等 .声学造影在肾囊肿硬化治疗中的应用[J]. 中国中西医结合肾病杂志, 2014, 15(5): 415-416.
[14]	Yong HK, Cho BS. Predictors of the frequency of ethanol injections for renal cyst ablation: a preliminary study[J]. Journal of the Korean Society of Radiology, 2018, 78(3): 193.
[15]	Gaballa D, Moyer M. Thoughts of the safety and efficacy of EUS-guided cyst ablation with the use of lauromacrogol[J]. Gastrointestinal Endoscopy, 2018, 87(5): 1367.

术后随访		囊肿容积（mL）				比例（%）
术后随访		< 50	50~100	100~150	> 150	比例（%）
1个月
	治愈	3	0	2	0	11.9（5/42）
	有效	5	7	3	5	47.6（20/42）
	总有效率	8	7	5	5	59.5（25/42）
	无效	3	3	6	5	40.5（17/42）
3个月
	治愈	8	3	4	0	35.7（15/42）
	有效	2	5	5	8	47.6（20/42）
	总有效率	10	8	9	8	83.3（35/42）
	无效	1	2	2	2	16.7（7/42）
9个月
	治愈	8	4	5	1	42.9（18/42）
	有效	2	4	6	9	50.0（21/42）
	总有效率	10	8	11	10	92.9（39/42）
	无效	1	2	0	0	7.1（3/42）
12个月
	治愈	8	8	7	2	59.5（25/42）
	有效	3	2	4	8	92.9（17/42）
	总有效率	11	10	11	10	100.0（42/42）
	无效	0	0	0	0	0.0（0/42）

术后随访		囊肿容积（mL）				比例（%）
术后随访		< 50	50~100	100~150	> 150	比例（%）
1个月
	治愈	3	0	2	0	11.9（5/42）
	有效	5	7	3	5	47.6（20/42）
	总有效率	8	7	5	5	59.5（25/42）
	无效	3	3	6	5	40.5（17/42）
3个月
	治愈	8	3	4	0	35.7（15/42）
	有效	2	5	5	8	47.6（20/42）
	总有效率	10	8	9	8	83.3（35/42）
	无效	1	2	2	2	16.7（7/42）
9个月
	治愈	8	4	5	1	42.9（18/42）
	有效	2	4	6	9	50.0（21/42）
	总有效率	10	8	11	10	92.9（39/42）
	无效	1	2	0	0	7.1（3/42）
12个月
	治愈	8	8	7	2	59.5（25/42）
	有效	3	2	4	8	92.9（17/42）
	总有效率	11	10	11	10	100.0（42/42）
	无效	0	0	0	0	0.0（0/42）

因素	β值	标准误	95%CI	P值
性别	0.272	0.262	0.758~2.196	0.299
年龄	0.296	0.295	0.753~2.398	0.317
囊肿位置	0.042	0.178	0.735~1.480	0.814
囊肿容积	-0.474	0.128	0.484~0.801	0.000
囊液颜色	-0.351	0.409	0.316~1.569	0.390

因素	β值	标准误	95%CI	P值
性别	0.272	0.262	0.758~2.196	0.299
年龄	0.296	0.295	0.753~2.398	0.317
囊肿位置	0.042	0.178	0.735~1.480	0.814
囊肿容积	-0.474	0.128	0.484~0.801	0.000
囊液颜色	-0.351	0.409	0.316~1.569	0.390

Please choose a citation manager

Content to export